& Takagi, H
Contact your healthcare provider promptly if you experience: Severe or persistent abdominal pain , particularly if accompanied by nausea and vomiting, as this may indicate pancreatitis (a rare but serious side effect of GLP-1 receptor agonists) Unexplained muscle pain, tenderness, or weakness , especially if accompanied by dark urine or fatigue, as this may indicate a rare muscle condition associated with statins Symptoms of dehydration such as dizziness, reduced urination, or extreme thirst, particularly if experiencing significant gastrointestinal side effects from Wegovy Right upper abdominal pain, fever or jaundice , which may indicate gallbladder problems (more common with Wegovy, especially during rapid weight loss) Yellowing of the skin or eyes , which may indicate liver problems Allergic reactions such as rash, swelling, or difficulty breathing Regular monitoring is important when taking statins
weeks 5 to 8 use 1.5 mg or 4.5 units
Semaglutide works by activating GLP-1 receptors in the brain to reduce hunger and improve insulin sensitivity, helping patients lose an average of 5-10% of body weight within 12 weeks
The ALDH1L1 encoded enzyme was originally identified as 10-formyl tetrahydrofolate dehydrogenase (FTHFD
GLP-1 refers to prescription medication your clinician may use as part of a weight management plan